| Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results |
Globe Newswire |
08/14 |
08:00 |
| Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update |
Globe Newswire |
08/14 |
08:00 |
| American Fusion Inc. (OTC: AMFN) Provides Update on Global Fusion Industry, Texas Data Center and Critical Infrastructure Energy Markets, and Engages Securities Counsel |
Globe Newswire |
08/14 |
08:00 |
| Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease |
Globe Newswire |
08/14 |
08:00 |
| Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign |
Globe Newswire |
08/14 |
08:00 |
| Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update |
Globe Newswire |
08/14 |
08:00 |
| Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update |
Globe Newswire |
08/14 |
08:00 |
| Foremost Clean Energy Grants Stock Options |
Globe Newswire |
08/14 |
08:00 |
| Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026 |
Globe Newswire |
08/14 |
08:00 |
| How Appinventiv is Solving AI Adoption Challenges for Global Enterprises |
Globe Newswire |
08/14 |
07:55 |
| SurgePays Reports Q2 2026 Revenue Growth of 40.7% Year-Over-Year to $16.2 Million, Reports Positive Net Income of $1.29 Million |
Globe Newswire |
08/14 |
07:45 |
| LanzaTech Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/14 |
07:45 |
| Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance |
Globe Newswire |
08/14 |
07:30 |
| Beneficient Reports First Quarter Fiscal 2027 Results |
Globe Newswire |
08/14 |
07:30 |
| Base Carbon Reports Second-Quarter 2026 Operating and Financial Results |
Globe Newswire |
08/14 |
07:30 |
| Milestone Scientific Reports Financial Results for Second Quarter 2026 |
Globe Newswire |
08/14 |
07:30 |
| Edible Garden Reports Second Quarter 2026 Results; Revenue Grows 12.8%, Sales Increase 31.2% as Company Accelerates Farm-to-Formula® Strategy |
Globe Newswire |
08/14 |
07:30 |
| Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks |
Globe Newswire |
08/14 |
07:30 |
| Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights |
Globe Newswire |
08/14 |
07:28 |
| Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™ |
Globe Newswire |
08/14 |
07:15 |
| A free, AI-powered youth entrepreneurship platform, “Dear Dreamer,” launches, built at the Martin Trust Center for MIT Entrepreneurship and made possible through a gift by the Frank & Eileen Foundation |
Globe Newswire |
08/14 |
07:05 |
| Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial |
Globe Newswire |
08/14 |
07:00 |
| Beyond Meat Announces Effectiveness of 1-for-30 Reverse Stock Split |
Globe Newswire |
08/14 |
07:00 |
| Aurora Mobile and Exabytes Sign Three-Year Strategic MoU to Bring AI-Powered Customer Engagement to Businesses Across Southeast Asia |
Globe Newswire |
08/14 |
07:00 |
| Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update |
Globe Newswire |
08/14 |
07:00 |
